OTC Pharmaceuticals - Kazakhstan | Statista Market Forecast

Revenue in the OTC Pharmaceuticals market amounts to US$631.90m in 2024. The market is expected to grow annually by 1.91% (CAGR 2024-2029).
The market's largest segment is the segment Vitamins & Minerals with a market volume of US$197.10m in 2024.
In global comparison, most revenue is generated United States (US$41bn in 2024).
In relation to total population figures, per person revenues of US$31.87 are generated in 2024.
In the OTC Pharmaceuticals market, 0.6% of total revenue will be generated through online sales by 2024.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Kazakhstan has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.

Customer preferences in the OTC Pharmaceuticals market in Kazakhstan have shifted towards self-medication and preventive healthcare. Consumers are increasingly seeking easy access to affordable and effective healthcare products without the need for a prescription. This trend is driven by the convenience and cost-effectiveness of OTC medications, as well as the growing awareness of the importance of taking proactive measures to maintain good health.

Trends in the market reflect the changing healthcare landscape in Kazakhstan. The government has been implementing reforms to improve the accessibility and affordability of healthcare services, including the promotion of OTC medications. This has led to an expansion of the OTC Pharmaceuticals market, with a wider range of products available to consumers.

In addition, there has been a growing emphasis on preventive healthcare, which has further boosted the demand for OTC medications. Local special circumstances in Kazakhstan have also played a role in the development of the OTC Pharmaceuticals market. The country has a large rural population, with limited access to healthcare facilities.

OTC medications provide a convenient and cost-effective solution for individuals living in remote areas, where access to prescription drugs may be limited. Furthermore, the growing middle class in Kazakhstan has increased disposable incomes and purchasing power, leading to a higher demand for OTC medications. Underlying macroeconomic factors have also contributed to the growth of the OTC Pharmaceuticals market in Kazakhstan.

The country has experienced steady economic growth in recent years, which has led to an increase in consumer spending. This has created a favorable environment for the OTC Pharmaceuticals market to thrive. Additionally, the aging population in Kazakhstan has resulted in a higher demand for healthcare products, including OTC medications, as individuals seek to manage age-related health conditions.

In conclusion, the OTC Pharmaceuticals market in Kazakhstan is developing due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication and preventive healthcare, government reforms, limited access to healthcare facilities in rural areas, and the growing middle class and aging population have all contributed to the growth of this market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Consumer market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.